Ebola Treatment Stalled by Sample Wars

Scientists racing to tackle the current Ebola outbreak face a major roadblock: they’re forced to rely on outdated virus samples from past outbreaks, making it hard to trust whether new treatments will work. The real problem? No fresh samples are coming from the Democratic Republic of Congo, sparking global tensions over who controls biological materials and who benefits from research. While the virus’s genetics are similar to older strains, researchers desperately need current samples to test with confidence. This crisis exposes deep flaws in global pathogen-sharing systems—and highlights how slow progress on WHO reforms could cost lives. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/0475beac4e6eff9b